Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Talaris Therapeutics Announces Initiation of Phase 2 Clinical Trial of FCR001 in Delayed – KULR-8,

This trial will explore the safety and efficacy of the company’s investigational allogeneic cell therapy, FCR001, to induce immune tolerance to a …, This trial will explore the safety and efficacy of the company’s investigational allogeneic cell therapy, FCR001, to induce immune tolerance to a …, Read More

Scroll to Top